These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23420550)

  • 21. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
    Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
    Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
    Patenaude AF; Dorval M; DiGianni LS; Schneider KA; Chittenden A; Garber JE
    J Clin Oncol; 2006 Feb; 24(4):700-6. PubMed ID: 16446344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.
    Claes E; Evers-Kiebooms G; Boogaerts A; Decruyenaere M; Denayer L; Legius E
    Am J Med Genet A; 2003 Jan; 116A(1):11-9. PubMed ID: 12476445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence.
    de Juan Jiménez I; García Casado Z; Palanca Suela S; Esteban Cardeñosa E; López Guerrero JA; Segura Huerta Á; Chirivella González I; Sánchez Heras AB; Juan Fita MJ; Tena García I; Guillen Ponce C; Martínez de Dueñas E; Romero Noguera I; Salas Trejo D; Goicoechea Sáez M; Bolufer Gilabert P
    Fam Cancer; 2013 Dec; 12(4):767-77. PubMed ID: 23479189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain.
    Sanz J; Ramón y Cajal T; Torres A; Darder E; Gadea N; Velasco A; Fortuny D; López C; Fisas D; Brunet J; Alonso MC; Balmaña J
    Fam Cancer; 2010 Sep; 9(3):297-304. PubMed ID: 20091130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Family communication matters: the impact of telling relatives about unclassified variants and uninformative DNA-test results.
    Vos J; Jansen AM; Menko F; van Asperen CJ; Stiggelbout AM; Tibben A
    Genet Med; 2011 Apr; 13(4):333-41. PubMed ID: 21358410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disclosure of genetics research results after the death of the patient participant: a qualitative study of the impact on relatives.
    Ormondroyd E; Moynihan C; Watson M; Foster C; Davolls S; Ardern-Jones A; Eeles R
    J Genet Couns; 2007 Aug; 16(4):527-38. PubMed ID: 17492498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients.
    Landsbergen K; Verhaak C; Kraaimaat F; Hoogerbrugge N
    Fam Cancer; 2005; 4(2):115-9. PubMed ID: 15951961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling.
    Høberg-Vetti H; Eide GE; Siglen E; Listøl W; Haavind MT; Hoogerbrugge N; Bjorvatn C
    Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
    Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
    Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.
    Tercyak KP; Peshkin BN; Demarco TA; Patenaude AF; Schneider KA; Garber JE; Valdimarsdottir HB; Schwartz MD
    Genet Test; 2007; 11(3):249-55. PubMed ID: 17949286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrafamilial communication of hereditary breast and ovarian cancer genetic information in Italian women: towards a personalised approach.
    Di Pietro ML; Zaçe D; Orfino A; Di Raimo FR; Poscia A; de Matteis E; Turchetti D; Godino L; Bertonazzi B; Franiuk M; Bruzzone C; Varesco L; Lucci-Cordisco E; Genuardi M
    Eur J Hum Genet; 2021 Feb; 29(2):250-261. PubMed ID: 32929237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of an intervention for individuals and families with BRCA mutations: a model for providing medical updates and psychosocial support following genetic testing.
    McKinnon W; Naud S; Ashikaga T; Colletti R; Wood M
    J Genet Couns; 2007 Aug; 16(4):433-56. PubMed ID: 17594133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters.
    Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A
    Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
    Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Implementing B-RST
    Wernke K; Bellcross C; Gabram S; Ali N; Stanislaw C
    Clin Breast Cancer; 2019 Aug; 19(4):e547-e555. PubMed ID: 31005475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.
    Bellcross CA; Leadbetter S; Alford SH; Peipins LA
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):728-35. PubMed ID: 23371291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutations.
    Alegre N; Perre PV; Bignon YJ; Michel A; Galibert V; Mophawe O; Corsini C; Coupier I; Chiesa J; Robert L; Bernhard L; Picot MC; Bertet H; Macioce V; Bastide N; Solassol J; Rey JM; Thomas F; Carton S; Pujol P
    Psychooncology; 2019 Aug; 28(8):1679-1686. PubMed ID: 31152683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects.
    Tercyak KP; Demarco TA; Mars BD; Peshkin BN
    Am J Med Genet A; 2004 Nov; 131(1):36-41. PubMed ID: 15389697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.